OPS
ZYNE

Orion Portfolio Solutions’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Orion Portfolio Solutions’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-20
Closed – – 2198
2020
Q2 		$0 Hold
20
– – ﹤0.01% 2524
2020
Q1 		$0 Buy
+20
New +$93 ﹤0.01% 2396

Other funds holding ZYNE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Orion Portfolio Solutions's ZYNE Position: Q3 2020 in Review

Orion Portfolio Solutions sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q3 2020, closing a stake of 20 shares.

Orion Portfolio Solutions first reported a position in ZYNE in Q1 2020 and held it in 2 quarters. The position peaked at $0 in Q2 2020. 66 funds tracked by Wall St. Rank hold ZYNE as of Q3 2020.

  • Orion Portfolio Solutions reported no remaining Zynerba Pharmaceuticals, Inc position as of Q3 2020 after selling out during the quarter.
  • Orion Portfolio Solutions sold 20 Zynerba Pharmaceuticals, Inc shares in Q3 2020.
  • Orion Portfolio Solutions first reported a position in Zynerba Pharmaceuticals, Inc in Q1 2020 and held it in 2 quarters.
  • Orion Portfolio Solutions's Zynerba Pharmaceuticals, Inc position peaked at $0 in Q2 2020.
  • 66 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q3 2020.

Based on Orion Portfolio Solutions's 13F filing for Q3 2020, filed 13 Nov 2020.